PODCAST · science
Inside Modern Biotech
by Biotechnologyguy: Shubham Thorat
A podcast exploring the tools, technologies and breakthroughs reshaping biology.Each episode dives into one powerful concept—like CRISPR, CAR-T, AlphaFold or mRNA vaccines breaking it down in simple but scientifically solid language for students, researchers and curious minds. From gene editing and synthetic biology to AI in drug discovery, Inside Modern Biotech takes you from the lab bench to real-world impact.
-
6
A Vitamin You Can Buy at Any Pharmacy Just Helped Double Chemotherapy Success Rates in Breast Cancer
Researchers in Brazil ran a randomized controlled trial on 80 women undergoing chemotherapy for breast cancer. One group took 2,000 IU of vitamin D daily. The other took a placebo. After six months, 43% of the vitamin D group had no cancer left by the time of surgery. In the placebo group, only 24% did.That is a 79% relative difference. From a supplement that costs a few dollars a month.In this episode, we break down what the study actually found, why the numbers need careful reading, and what a second independent trial from Turkey with 227 patients adds to the picture. We explain what vitamin D actually does inside cancer cells: how it pushes them toward self-destruction, cuts off their blood supply, and may make chemotherapy more effective.We also cover why so many breast cancer patients are deficient before treatment even begins, what dose was used and why it is considered safe, and what needs to happen before this changes standard clinical practice.This is not a story about a miracle supplement. It is a story about a real signal in real data, a biologically plausible mechanism, and what it could mean for patients in health systems where expensive cancer drugs are out of reach.Source: Omodei et al., Nutrition and Cancer, 2025. DOI: 10.1080/01635581.2025.2480854Supporting: Özkurt et al., World Journal of Surgery, 2025. DOI: 10.1002/wjs.12587
-
5
The Fossil That Waited 150 Million Years to Answer Darwin’s Question
In 1859, Darwin predicted the fossil record would reveal creatures caught mid-evolution. Two years later, workers in a German quarry found one: feathers of a bird, teeth of a lizard. They called it Archaeopteryx. For 164 years, one question stayed unanswered: could it actually fly?In this episode, we walk through the Chicago Archaeopteryx — the 14th and smallest known specimen, acquired by the Field Museum in 2022, still encased in rock. After 1,300 hours of preparation using UV light and CT scanning, what emerged was unlike anything seen in 160 years of study.We cover the soft tissue glowing under UV. The tertial feathers that finally settled the flight debate. What the roof of the mouth tells us about how rigid dinosaur skulls became the nimble, kinetic structures of modern birds. And the finding hiding beneath it all: flight may have evolved not once, but multiple times across the dinosaur family tree.A 150-million-year-old animal. A 165-year argument. The moment science finally got a good enough look to settle it.Source: O’Connor et al., Nature, May 2025. DOI: 10.1038/s41586-025-08912-4
We're indexing this podcast's transcripts for the first time — this can take a minute or two. We'll show results as soon as they're ready.
No matches for "" in this podcast's transcripts.
No topics indexed yet for this podcast.
Loading reviews...
ABOUT THIS SHOW
A podcast exploring the tools, technologies and breakthroughs reshaping biology.Each episode dives into one powerful concept—like CRISPR, CAR-T, AlphaFold or mRNA vaccines breaking it down in simple but scientifically solid language for students, researchers and curious minds. From gene editing and synthetic biology to AI in drug discovery, Inside Modern Biotech takes you from the lab bench to real-world impact.
HOSTED BY
Biotechnologyguy: Shubham Thorat
Loading similar podcasts...